Amundi Funds - US Equity Research Value F2 EUR Hgd (C)Register to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 7.2 | 16.1 | -9.4 | 0.6 | -0.5 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 16/05/2024 | EUR 6.25 | |
Day Change | 0.05% | |
Morningstar Category™ | Other Equity | |
ISIN | LU1894684155 | |
Fund Size (Mil) 16/05/2024 | EUR 542.94 | |
Share Class Size (Mil) 16/05/2024 | EUR 0.23 | |
Max Initial Charge | - | |
Ongoing Charge 15/03/2024 | 2.68% |
Investment Objective: Amundi Funds - US Equity Research Value F2 EUR Hgd (C) |
Seeks to increase the value of your investment over the recommended holding period. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Ashesh Savla 15/12/2015 | ||
Craig Sterling 29/05/2015 | ||
Inception Date 24/06/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Russell 1000 Value TR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Funds - US Equity Research Value F2 EUR Hgd (C) | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Coca-Cola Co | Consumer Defensive | 4.99 |
Cisco Systems Inc | Technology | 4.59 |
JPMorgan Chase & Co | Financial Services | 3.98 |
The Walt Disney Co | Communication Services | 3.79 |
Pfizer Inc | Healthcare | 3.60 |
Increase Decrease New since last portfolio | ||
Amundi Funds - US Equity Research Value F2 EUR Hgd (C) |